More support for angioplasty vs thrombolysis
This article was originally published in Clinica
Mortality is lower among heart attack patients treated with primary angioplasty than among those who receive thrombolytic therapy, unless the hospital only performs a low volume of angioplasties, in which case there is no difference between the two groups. This is the conclusion of a 62,299-patient retrospective cohort study based at Colorado Permanente Medical Group and the University of Colorado Health Sciences Center in Denver, which was published in the December 27 issue of the Journal of the American Medical Association. The findings of the study will fuel the continuing debate about which type of treatment is more appropriate.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.